Investor Presentaiton

FY19 Guidance Consolidated Revenues . Low double digit growth over FY18 R&D Investments • Approximately 8%-9% of revenues to be invested in R&D Investing for Future © Sun Pharmaceutical Industries Limited. All Rights Reserved. . • Invest in R&D and in building the specialty business SUN PHARMA 54

View entire presentation